GLP-1 SM 15mg Peptides
For researchers who refuse to compromise, precision begins with the integrity of every vial.
GLP-1 SM 15mg is a lyophilized peptide vial designed for controlled laboratory work where consistency and clarity matter. This unflavored, freeze-dried format contains a single active ingredient, prepared for reconstitution under validated lab protocols. Each vial delivers a total content of 15mg, supporting repeatable method development and reliable assay performance.
- Each vial contains 15mg of GLP-1 SM, supporting incretin-pathway investigations, receptor-binding and signaling studies, and protocol optimization where purity, identity, and reproducibility are essential.
This is a non-consumable, research-only lyophilized powder. Researchers can expect a clean, uniform matrix engineered for predictable dissolution when handled with appropriate sterile technique and buffered systems suitable to the intended assay. The vialed format is selected to support material stability and traceable handling, facilitating controlled aliquoting, minimized exposure, and streamlined documentation within regulated lab environments.
Primavora prioritizes rigorous standards at every step. Each lot is produced in controlled facilities and released only after verification of identity and purity using appropriate analytical methods. Batch-level documentation is maintained to support traceability and quality review. Vials are handled with care from fill to fulfillment, with packaging designed to protect against light and environmental stress during standard laboratory transport and storage practices.
Quality and compliance are foundational to this product: premium sourcing, careful lyophilization, and methodical handling help ensure a consistent research experience from one batch to the next. Our team emphasizes transparency, offering clear labeling and access to documentation so investigators can align materials to protocol requirements with confidence.
Research Use Only. Not for human consumption or injection. Not a drug, food, or cosmetic. For qualified laboratory personnel and controlled research settings only. Use in accordance with applicable laws, regulations, and institutional guidelines. Store and handle under appropriate laboratory conditions.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is GLP-1 SM?
GLP-1 SM appears to be a supplier-specific GLP-1-based research product. The 'SM' label is not a standardized pharmacologic name, so a careful description should avoid guessing the exact analog unless the sequence or active ingredient is shown on the specification sheet. It is best framed as a GLP-1-pathway research compound for laboratory use only.
What is GLP-1 SM typically studied for?
GLP-1-based compounds are generally studied for appetite regulation, glucose handling, insulin-related signaling, and body-weight change in metabolic models. For this specific item, the strongest FAQ wording is to explain the GLP-1 research category while also telling users to confirm the exact analog on the lot documents.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Prima Vora are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
